Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis

Adriamycin (ADR) has been utilized to treat cancer for several decades. However, ADR-induced renal injury is one of the most common side effects accompanying ADR therapy. In the present study, we revealed that astragaloside IV (ASIV) was beneficial for renal injury caused by Adriamycin. We demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Lu-Yun, Guan, Peng, Wang, Jian-Xin, Chen, Yu, Zhao, Ya-Shuo, Yang, Sheng-Chang, Guo, Ya-Jing, Wang, Na, Ji, En-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971812/
https://www.ncbi.nlm.nih.gov/pubmed/35370757
http://dx.doi.org/10.3389/fphar.2022.812594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971812/
https://www.ncbi.nlm.nih.gov/pubmed/35370757
http://dx.doi.org/10.3389/fphar.2022.812594

Ejemplares similares